Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV 2 Infection)

Respiratory
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
1100%

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Atea Pharmaceuticals
1 program
1
BemnifosbuvirPhase 3Small Molecule1 trial
Active Trials
NCT05629962CompletedEst. May 2024

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
Atea PharmaceuticalsBemnifosbuvir

Clinical Trials (1)

SUNRISE-3: Efficacy and Safety of Bemnifosbuvir in High-Risk Outpatients With COVID-19

Start: Nov 2022Est. completion: May 2024
Phase 3Completed

Related Jobs in Respiratory

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
1 companies competing in this space